MyFinsight
Home
Blog
About
Marketable securities,
current
$175,053K
(28.34%↑ Y/Y)
Cash and cash
equivalents
$78,610K
(0.58%↑ Y/Y)
Prepaid expenses and
other current assets
$7,905K
(-1.40%↓ Y/Y)
Accounts receivable
$1,334K
(-38.18%↓ Y/Y)
Total current assets
$262,902K
(16.99%↑ Y/Y)
Marketable securities,
non-current
$46,786K
(455.72%↑ Y/Y)
Right-of-use asset
$37,637K
(-30.58%↓ Y/Y)
Other assets
$4,487K
(2420.79%↑ Y/Y)
Property and equipment,
net
$4,149K
(-25.11%↓ Y/Y)
Restricted cash
$3,443K
(0.00%↑ Y/Y)
Total assets
$359,404K
(21.20%↑ Y/Y)
Total liabilities and
stockholders equity
$359,404K
(21.20%↑ Y/Y)
Total stockholders
equity
$247,265K
(42.05%↑ Y/Y)
Total liabilities
$112,139K
(-8.43%↓ Y/Y)
Accumulated deficit
-$787,457K
(-14.78%↓ Y/Y)
Accumulated other
comprehensive income
-$444K
(-1380.00%↓ Y/Y)
Additional paid-in capital
$1,035,154K
(20.35%↑ Y/Y)
Operating lease
liability, net of current
$50,178K
(-11.75%↓ Y/Y)
Total current
liabilities
$48,247K
(8.53%↑ Y/Y)
Deferred revenue, net of
current
$13,714K
(-35.16%↓ Y/Y)
Common stock, par value
of 0.0001 per share...
$12K
(71.43%↑ Y/Y)
Deferred revenue,
current
$26,661K
(17.86%↑ Y/Y)
Accrued expenses and
other current...
$13,785K
(1.70%↑ Y/Y)
Operating lease
liability, current
$6,680K
(10.12%↑ Y/Y)
Accounts payable
$1,121K
(-49.41%↓ Y/Y)
Back
Back
Balance Sheet
C4 Therapeutics, Inc. (CCCC)
C4 Therapeutics, Inc. (CCCC)
source: myfinsight.com